Bob Pang
Papers
1
Total Citations
10
H-Index
1
About
Bob Pang is a leading researcher in the field of pharmaceutical compounding and intravenous (IV) oncology infusion safety. His work focuses on the critical intersection of automation, gravimetrics, and quality assurance within sterile compounding workflows. Pang’s major contribution lies in the direct, empirical comparison of two cutting-edge technologies—robotic systems and gravimetric technology-assisted workflow (TAWF) platforms—for preparing IV oncology infusions. His landmark 2020 study, which has garnered 10 citations, is pivotal for its rigorous methodology: by using the same gravimetric quality assurance system to evaluate both platforms, he provided an objective, head-to-head analysis of their accuracy and efficiency. This research offers actionable insights for hospital pharmacies seeking to reduce medication errors and improve patient safety in high-risk chemotherapy compounding. Beyond this core study, Pang’s work helps define best practices for integrating automation into clinical workflows, making him a key voice in the ongoing shift toward safer, more reliable IV preparation. His findings are essential reading for pharmacy informaticists, oncology pharmacists, and researchers interested in the future of sterile compounding technology.
Research Focus
Key Achievements
Top Papers
- 1